{"abstract":"This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to MeiraGTx, having a principal place of business in New York, New York, U.S.A. to practice the inventions embodied in the following patent applications, entitled \"AAV-mediated aquaporin gene transfer to treat Sj[ouml]gren's syndrome\":","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/04/29/2016-09978.html","cfr_references":[],"citation":"81 FR 25683","comment_url":null,"comments_close_on":"2016-05-16","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license that are received by the National Institute of Dental and Craniofacial Research, Office of Technology Transfer and Innovation Access on or before May 16, 2016 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2016-09978","effective_on":null,"end_page":25683,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/04/29/2016-09978.xml","html_url":"https://www.federalregister.gov/documents/2016/04/29/2016-09978/prospective-grant-of-exclusive-license-aav-mediated-aquaporin-gene-transfer-to-treat-sjgrens","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-09978?publication_date=2016-04-29","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-04-29/2016-09978/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":216,"last_updated":"2026-09-21 02:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-04-29/pdf/2016-09978.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-09978.pdf?1461847539","publication_date":"2016-04-29","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/04/29/2016-09978.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T08:43:51Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":25683,"subtype":null,"title":"Prospective Grant of Exclusive License: AAV-Mediated Aquaporin Gene Transfer To Treat Sjögren's Syndrome","toc_doc":"AAV-Mediated Aquaporin Gene Transfer to Treat Sjogren's Syndrome","toc_subject":"Prospective Grant of Exclusive Licenses:","topics":[],"type":"Notice","volume":81}